Insiders Trades

★ Sign in to follow

TW

Toby Wegman

Executive

US·SEC (Form 4)

Biospecifics Technologies Corp

Cumul. flow

Total declarations

21

Company

1

▲ Purchases (0 ops.)

—

▼ Sales (16 ops.)

€2.8M

Latest filing published 02 Dec 2020 for BIOSPECIFICS TECHNOLOGIES CORP.

Filing timeline

BuySale

Toby Wegman

Insider track record

Disclosed buys

0

Disclosed sells

16

Signal history

Toby Wegman: trading record in brief

Toby Wegman is a declared insider of Biospecifics Technologies Corp, with filings sourced from SEC (Form 4). Over a trading history stretching from 18 May 2016 to 2 December 2020, the count stands at 21 filings.

No open-market purchase appears, only 16 sales worth €2.8M. Outside the open market, there are 2 share grants.

On 2 December 2020 came the latest disclosure, a transaction in Biospecifics Technologies Corp. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Toby Wegman

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Biospecifics Technologies Corp (US)

Declarations15 total

●

DirectorExecutives2 Dec 2020Biospecifics Technologies Corp

0SEC

1,890 sharesCommon Stock, $0.001 par valueSEC:0000899243-20-032456:0

●

DirectorExecutives2 Dec 2020Biospecifics Technologies Corp

0SEC

1,726 sharesCommon Stock, $0.001 par valueSEC:0000899243-20-032456:1

●

DirectorExecutives2 Dec 2020Biospecifics Technologies Corp

0SEC

935,073 sharesCommon Stock, $0.001 par valueSEC:0000899243-20-032456:2

◆

DirectorExecutives15 Jul 2020Biospecifics Technologies Corp

0SEC

1,726 shares0Common Stock, $0.001 par valueSEC:0000899243-20-019551:0

▼

DirectorExecutives9 Sept 2019Biospecifics Technologies Corp

60,753 USD12SEC

1,100 shares@ US$55.235.9% of flowCommon Stock, $0.001 par valueSEC:0001062993-19-003653:0

▼

DirectorExecutives10 Sept 2019Biospecifics Technologies Corp

490,924 USD16SEC

8,900 shares@ US$55.1647.8% of flowCommon Stock, $0.001 par valueSEC:0001062993-19-003653:1

◆

DirectorExecutives1 Jul 2019Biospecifics Technologies Corp

0SEC

1,890 shares0Common Stock, $0.001 par valueSEC:0001062993-19-002781:0

▼

DirectorExecutives21 May 2019Biospecifics Technologies Corp

345,870 USD32SEC

5,400 shares@ US$64.0533.3% of flowCommon Stock, $0.001 par valueSEC:0001062993-19-002375:0

▼

DirectorExecutives21 May 2019Biospecifics Technologies Corp

6,467 USD29SEC

100 shares@ US$64.670.6% of flowCommon Stock, $0.001 par valueSEC:0001062993-19-002375:1

▼

DirectorExecutives17 Aug 2018Biospecifics Technologies Corp

129,725 USD27SEC

2,500 shares@ US$51.8912.3% of flowCommon Stock, $0.001 par valueSEC:0001062993-18-003491:0

▼

DirectorExecutives29 Nov 2016Biospecifics Technologies Corp

Same trade as the filing by Thomas Wegman, counted once

480,800 USD25SEC

10,000 shares@ US$48.0816.1% of flowCommon Stock, $.001 par valueSEC:0001062993-16-012534:0

▼

DirectorExecutives15 Sept 2016Biospecifics Technologies Corp

Same trade as the filing by Thomas Wegman, counted once

127,751 USD23SEC

3,100 shares@ US$41.214.1% of flowCommon Stock, $.001 par valueSEC:0001062993-16-011508:0

▼

DirectorExecutives13 Sept 2016Biospecifics Technologies Corp

135,368 USD23SEC

3,605 shares@ US$37.554.3% of flowCommon Stock, $.001 par valueSEC:0001062993-16-011441:0

▼

PresidentExecutives1 Sept 2016Biospecifics Technologies Corp

Same trade as the filing by Thomas Wegman, counted once

297,801 USD35SEC

7,935 shares@ US$37.539.5% of flowCommon Stock, $.001 par valueSEC:0001062993-16-011378:0

▼

PresidentExecutives2 Sept 2016Biospecifics Technologies Corp

Same trade as the filing by Thomas Wegman, counted once

47,475 USD34SEC

1,266 shares@ US$37.501.5% of flowCommon Stock, $.001 par valueSEC:0001062993-16-011378:1

▼

PresidentExecutives29 Aug 2016Biospecifics Technologies Corp

Same trade as the filing by Thomas Wegman, counted once

60,439 USD34SEC

1,607 shares@ US$37.611.9% of flowCommon Stock, $.001 par valueSEC:0001062993-16-011355:0

▼

PresidentExecutives30 Aug 2016Biospecifics Technologies Corp

Same trade as the filing by Thomas Wegman, counted once

100,950 USD34SEC

2,692 shares@ US$37.503.2% of flowCommon Stock, $.001 par valueSEC:0001062993-16-011355:1

▼

DirectorExecutives18 May 2016Biospecifics Technologies Corp

5,121 USD23SEC

150 shares@ US$34.140.2% of flowCommon Stock, $0.001 par valueSEC:0001062993-16-009883:1

▼

DirectorExecutives18 May 2016Biospecifics Technologies Corp

1,706 USD23SEC

50 shares@ US$34.110.1% of flowCommon Stock, $0.001 par valueSEC:0001062993-16-009883:2

▼

DirectorExecutives18 May 2016Biospecifics Technologies Corp

816,750 USD26SEC

24,750 shares@ US$33.0026.0% of flowCommon Stock, $0.001 par valueSEC:0001062993-16-009883:3

▼

DirectorExecutives18 May 2016Biospecifics Technologies Corp

1,690 USD23SEC

50 shares@ US$33.800.1% of flowCommon Stock, $0.001 par valueSEC:0001062993-16-009883:0

21 of 15 declarations